Referensi Tuberkulosis L

1. Lai CC, Lee MT, Lee SH, Hsu WT, Chang SS, Chen SC, Lee CC. Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort. Thorax. 2016 Jul 1;71(7):646-51.
2. Lai, T.C., Chiang, C.Y., Wu, C.F., Yang, S.L., Liu, D.P., Chan, C.C. and Lin, H.H., 2016. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and environmental medicine, 73(1), pp.56-61.
3. Laili, F., Ronoatmodjo, S. and Murtiani, F., 2024. Ko-Infeksi TB-HIV terhadap Kegagalan Pengobatan Pasien Tuberkulosis Resistan Obat di Indonesia. The Indonesian Journal of Infectious Diseases, 10(2), pp.153-165.
4. Lam WJ, Chan KK, Wang G, Lai CK, Kang G, Chan C, Leung AC, Wong NH, Tso CS, Chow KM, Ramakrishnan S. Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis. NEJM evidence. 2026 Mar 24;5(4):EVIDoa2500237.
5. Langley, I., Doulla, B., Lin, H.H., Millington, K. and Squire, B., 2012. Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health care management science, 15, pp.239-253.
6. Langley, I., Lin, H.H., Egwaga, S., Doulla, B., Ku, C.C., Murray, M., Cohen, T. and Squire, S.B., 2014. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. The Lancet Global Health, 2(10), pp.e581-e591.
7. Larsson L, Calderwood CJ, Marambire ET, Held K, Banze D, Mfinanga A, Madziva K, Walsh P, Jacob J, Fernandez FT, Lungu P. Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa. Clinical Infectious Diseases. 2025 Dec 15;81(6):e600-11.
8. Law S, Fulcher I, Ashraf S, Bastard M, Docteur W, Franke MF, Guerra D, Hewison C, Huerga H, Khan M, Khan P. Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling. Clinical Infectious Diseases. 2026 Mar 15;82(3):e571-9.
9. Lee C-H, Lee M-C, Lin H-H, Shu C-C, Wang J-Y, et al. (2012) Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS ONE 7(5): e37978.
10. Lee, P.H., Lin, H.C., Huang, A.S.E., Wei, S.H., Lai, M.S. and Lin, H.H., 2014. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PloS one, 9(3), p.e92623.
11. Lee P-H, Fu H, Lai T-C, Chiang C-Y, Chan C-C, Lin H-H (2016) Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med 13(8): e1002072.
12. Lee, E.H., Lee, J.M., Kang, Y.A., Leem, A.Y., Kim, E.Y., Jung, J.Y., Park, M.S., Kim, Y.S., Kim, S.K., Chang, J. and Kim, S.Y., 2017. Prevalence and impact of diabetes mellitus among patients with active pulmonary tuberculosis in South Korea. Lung, 195, pp.209-215.
13. Lee, M.R., Huang, Y.P., Kuo, Y.T., Luo, C.H., Shih, Y.J., Shu, C.C., Wang, J.Y., Ko, J.C., Yu, C.J. and Lin, H.H., 2017. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clinical Infectious Diseases, 64(6), pp.719-727.
14. Lee, P.H., Fu, H., Lee, M.R., Magee, M. and Lin, H.H., 2018. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. The International Journal of Tuberculosis and Lung Disease, 22(1), pp.7-16.
15. Lee, M.R., Keng, L.T., Lee, M.C., Chen, J.H., Lee, C.H. and Wang, J.Y., 2024. Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan. Emerging Microbes & Infections, 13(1), p.2417855.
16. Lee, C.S., Ho, C.H., Liao, K.M., Wu, Y.C. and Shu, C.C., 2025. The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis. Journal of Infection and Public Health, p.102686.
17. Lestari, H., 2024. Analisis Epidemiologi Kejadian Tuberkulosis Di Provinsi Sulawesi Tenggara Tahun 2021-2023. Variable Research Journal, 1(02), pp.802-810.
18. Lestari, B.W., Nijman, G., Larasmanah, A., Soeroto, A.Y., Santoso, P., Alisjahbana, B., Chaidir, L., Andriyoko, B., Van Crevel, R. and Hill, P.C., 2024. Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. The Lancet Regional Health-Southeast Asia, 22:100294.
19. Li, H., Chee, C.B., Geng, T., Pan, A. and Koh, W.P., 2022. Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study. Clinical Infectious Diseases, 75(2), pp.213-220.
20. Li, Z., Liu, Q., Chen, L., Zhou, L., Qi, W., Wang, C., Zhang, Y., Tao, B., Zhu, L., Martinez, L. and Lu, W., 2024. Ambient air pollution contributed to pulmonary tuberculosis in China. Emerging Microbes & Infections, 13(1), p.2399275.
21. Li, J., Zhao, Y., Jiang, Y., Zhang, Y., Zhang, P., Shen, L. and Chen, Z., 2024. Prevalence and risk factors of diabetes in patients with active pulmonary tuberculosis: a cross-sectional study in two financially affluent China cities. Diabetes, Metabolic Syndrome and Obesity, pp.1105-1114.
22. Liang, L. and Su, Q., 2024. Prediabetes and the treatment outcome of tuberculosis: A meta‐analysis. Tropical Medicine & International Health, 29(9), pp.757-767.
23. Lin, H.H., Murray, M., Cohen, T., Colijn, C. and Ezzati, M., 2008. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. The Lancet, 372(9648), pp.1473-1483.
24. Lin, H.H., Ezzati, M., Chang, H.Y. and Murray, M., 2009. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. American journal of respiratory and critical care medicine, 180(5), pp.475-480.
25. Lin, H.H., Langley, I., Mwenda, R., Doulla, B., Egwaga, S., Millington, K.A., Mann, G.H., Murray, M., Squire, S.B. and Cohen, T., 2011. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. The International journal of tuberculosis and lung disease, 15(8), pp.996-1004.
26. Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asencios, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T., 2011. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology & Infection, 139(11), pp.1784-1793.
27. Lin, H.H., Dowdy, D., Dye, C., Murray, M. and Cohen, T., 2012. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization, 90, pp.739-747.
28. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T. Use of spatial information to predict multidrug resistance in tuberculosis patients, Peru. Emerg Infect Dis. 2012 May;18(5):811-3. doi: 10.3201/eid1805.111467.
29. Lin, H.H., Chiang, Y.T., Chuang, J.H., Yang, S.L., Chang, H.Y., Ezzati, M. and Murray, M., 2013. Exposure to secondhand smoke and risk of tuberculosis: prospective cohort study. PloS one, 8(10), p.e77333.
30. Lin, H.H., Suk, C.W., Lo, H.L., Huang, R.Y., Enarson, D.A. and Chiang, C.Y., 2014. Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis. The International journal of tuberculosis and lung disease, 18(5), pp.613-621.
31. Lin, H.H., Wang, L., Zhang, H., Ruan, Y., Chin, D.P. and Dye, C., 2015. Tuberculosis control in China: use of modelling to develop targets and policies. Bulletin of the World Health Organization, 93, pp.790-798.
32. Lin, H.H., Wu, C.Y., Wang, C.H., Fu, H., Lönnroth, K., Chang, Y.C. and Huang, Y.T., 2018. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases, 66(5), pp.699-705.
33. Lin, S.P., Chen, I.C., Lin, C.H., Hsiao, T.H., Liu, P.Y. and Chen, Y.M., 2025. Host Genetic Factors and Clinical Comorbidities Associated With Tuberculosis Risk. HLA, 106(3), p.e70384.
34. Liu, Q., You, N., Wen, J., Wang, J., Ge, Y., Shen, Y., Ding, X., Lu, P., Chen, C., Zhu, B. and Zhu, L., 2023. Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China. Clinical Infectious Diseases, 77(1), pp.103-111.
35. Liu, A., Liao, Y., Ye, J., Wang, Q., Huang, J., Tang, Y., & Feng, L. (2026). Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case–Control Study. ClinicoEconomics and Outcomes Research, 577874.
36. Liu, C.Y., Chen, R.T., Shu, C.C. and Lin, S.Y., 2025. Prevalence, clinical reasons and associated factors of extended treatment duration for drug susceptible tuberculosis–a real-world experience. Scientific Reports, 15(1), pp.1-8.
37. Liu, K.H., Xiao, Y.X. and Jou, R., 2024. Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study. Frontiers in Microbiology, 15, p.1439532.
38. Lo, H.Y., Yang, S.L., Lin, H.H., Bai, K.J., Lee, J.J., Lee, T.I. and Chiang, C.Y., 2016. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?. The International Journal of Tuberculosis and Lung Disease, 20(3), pp.376-382.
39. Lu, P., Zhang, Y., Liu, Q., Ding, X., Kong, W., Zhu, L. and Lu, W., 2021. Association of BMI, diabetes, and risk of tuberculosis: a population-based prospective cohort. International Journal of Infectious Diseases, 109, pp.168-173.
40. Lu, J.W., Mao, J.J., Zhang, R.R., Li, C.H., Sun, Y., Xu, W.Q., Zhuang, X., Zhang, B. and Qin, G., 2023. Association between long-term exposure to ambient air pollutants and the risk of tuberculosis: A time-series study in Nantong, China. Heliyon, 9(6).
41. Luo, D., Wang, F., Chen, S., Zhang, Y., Wang, W., Wu, Q., Ling, Y., Zhou, Y., Li, Y., Liu, K. and Chen, B., 2025. Application of the age-period-cohort model in tuberculosis. Frontiers in Public Health, 13, p.1486946.

Referensi Tuberkulosis C

1. Cadena, J., Rathinavelu, S., Lopez-Alvarenga, J.C. and Restrepo, B.I., 2019. The re-emerging association between tuberculosis and diabetes: lessons from past centuries. Tuberculosis, 116, pp.S89-S97.
2. Carr, B.Z., Briganti, E.M., Musemburi, J., Jenkin, G.A. and Denholm, J.T., 2022. Effect of chronic kidney disease on all-cause mortality in tuberculosis disease: an Australian cohort study. BMC Infectious Diseases, 22(1), p.116.
3. Cegielski, J.P. and McMurray, D.N., 2004. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. The international journal of tuberculosis and lung disease, 8(3), pp.286-298.
4. Cerqueira-Silva, T., Boaventura, V.S., Paixão, E.S., Sanchez, M., Leyrat, C., Ranzani, O., Barreto, M.L. and Pescarini, J.M., 2026. Long-term risk of death after tuberculosis diagnosis and treatment. Nature Medicine, pp.1-8.
5. Chakhaia, T., Blumberg, H.M., Kempker, R.R., Luo, R., Dzidzikashvili, N., Chincharauli, M., Tukvadze, N., Avaliani, Z., Stauber, C. and Magee, M.J., 2025. Lack of weight gain and increased mortality during and after treatment among adults with drug-resistant tuberculosis: a retrospective cohort study in Georgia, 2009–2020. ERJ Open Research.
6. Chan, P.C., Chiang, C.Y., Lee, P.H., Lo, H.Y., Chu, P.W., Chen, J.J., Kato, S. and Raviglione, M.C.B., 2025. Assessing the impact of the TB response in Taiwan–the journey towards ending TB. IJTLD open, 2(5), pp.251-259.
7. Chang, A., Wu, C. Z., Lin, J. D., Lee, C. N., Tsai, K. Y., Wu, P. H., & Hsieh, A. T. (2022). Prevalence and risk factors for latent tuberculosis among diabetes patients in Taiwan: A cross-sectional study. The Journal of Infection in Developing Countries, 16(04), 644-649.
8. Chang, J.T., Dou, H.Y., Yen, C.L., Wu, Y.H., Huang, R.M., Lin, H.J., Su, I.J. and Shieh, C.C., 2011. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. Journal of the Formosan Medical Association, 110(6), pp.372-381.
9. Charles, F., Lin, Y.D., Greig, J., Gurra, S., Morikawa, R., Graham, S.M. and Maha, A., 2024. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action, 14(3), pp.85-90.
10. Chaubey, G.K., Modanwal, R., Dilawari, R., Talukdar, S., Dhiman, A., Chaudhary, S., Patidar, A., Raje, C.I. and Raje, M., 2024. Chronic hyperglycemia impairs anti-microbial function of macrophages in response to Mycobacterium tuberculosis infection. Immunologic Research, 72(4), pp.644-653.
11. Chaw, L., Liew, S.Q. and Wong, J., 2022. Association between climate variables and pulmonary tuberculosis incidence in Brunei Darussalam. Scientific Reports, 12(1), p.8775.
12. Chaw, L., Hamid, R.A., Koh, K.S. and Thu, K., 2022. Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis. BMJ open respiratory research, 9(1).
13. Chaw L, Jeludin NH, Thu K. Prevalence and risk factors associated with tuberculosis mortality in Brunei Darussalam. Asian Pac J Trop Med 2023; 16(1): 9-15.
14. Chee, C.B.E., Kyi-Win, K., Tan, S. and Wang, Y.T., 2025. QuantiFERON-TB Gold Plus CD8+ T cell responses in contacts with tuberculosis disease and recent tuberculosis infection. Microbiology Spectrum, 13(12), pp.e01353-25.
15. Chen, C.C., Chiang, C.Y., Pan, S.C., Wang, J.Y. and Lin, H.H., 2015. Health system delay among patients with tuberculosis in Taiwan: 2003–2010. BMC infectious diseases, 15, pp.1-9.
16. Chen IW, Chang LC, Chang YJ, Lai YC, Hung KC. Association between iron deficiency anemia and the risk of new-onset tuberculosis infection: a matched cohort analysis. Frontiers in Nutrition. 2026 Jan 20;13:1727992.
17. Chen, J., Zha, S., Hou, J., Lu, K., Qiu, Y., Yang, R., Li, L., Yang, Y. and Xu, L., 2022. Dose–response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ open, 12(3), p.e050928.
18. Chen, R.T., Liu, C.Y., Lin, S.Y., Shu, C.C. and Sheng, W.H., 2024. The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription. Scientific Reports, 14(1), p.5631.
19. Chen, S., Zhang, W., Zheng, Z., Shao, X., Yang, P., Yang, X. and Nan, K., 2023. Unraveling genetic causality between type 2 diabetes and pulmonary tuberculosis on the basis of Mendelian randomization. Diabetology & Metabolic Syndrome, 15(1), pp.1-9.
20. Chen, S.C., Wang, T.Y., Tsai, H.C., Chen, C.Y., Lu, T.H., Lin, Y.J., You, S.H., Yang, Y.F. and Liao, C.M., 2022. Demographic Control Measure Implications of Tuberculosis Infection for Migrant Workers across Taiwan Regions. International journal of environmental research and public health, 19(16), p.9899.
21. Chen, S.Y., 2024. Trends and annual percentage changes in tuberculosis mortality estimated by Joinpoint regression and age-period-cohort analyses, Taiwan, 1978–2022. Scientific Reports, 14(1), p.29101.
22. Chen, X., Zhou, J., Yuan, Q., Zhang, R., Huang, C. and Li, Y., 2024. Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis. BMC Public Health, 24(1), p.163.
23. Chen, Z., Liu, Q., Song, R., Zhang, W., Wang, T., Lian, Z., Sun, X. and Liu, Y., 2021. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocrine Disorders, 21(1), p.123.
24. Chew, Y.R., Tay, J.Y., Kyaw, W.M., Chia, P.Y. and Ng, D.H.L., 2025. Subclinical disease among people with culture-confirmed pulmonary tuberculosis in Singapore-a retrospective study. International Journal of Infectious Diseases, 153, p.107768.
25. Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, et al. (2015) The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis. PLoS ONE 10(3): e0121698. doi:10.1371/journal. pone.0121698.
26. Chidambaram, V., Gupte, A., Wang, J.Y., Golub, J.E. and Karakousis, P.C., 2021. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clinical Infectious Diseases, 73(9), pp.e3409-e3418.
27. Chien, Y.C., Chang, C.H., Shu, C.C., Wang, H.C. and Yu, C.J., 2025. Adherence to Tuberculosis Infection Treatment and its Impact on Prevention of Tuberculosis Reactivation: A Retrospective Cohort Study from Taiwan. Journal of Infection and Public Health, p.102917.
28. Chiu, T. F., Yen, M. Y., Shie, Y. H., Huang, H. L., Chen, C. C., & Yen, Y. F. (2022). Determinants of latent tuberculosis infection and treatment interruption in long-term care facilities: A retrospective cohort study in Taiwan. Journal of Microbiology, Immunology and Infection, 55(6), 1310-1317.
29. Choi, H., Yoo, J.E., Han, K., Choi, W., Rhee, S.Y., Lee, H. and Shin, D.W., 2021. Body mass index, diabetes, and risk of tuberculosis: a retrospective cohort study. Frontiers in nutrition, 8, p.739766.
30. Choi, H., Han, K., Jung, J.H., Park, S.H., Kim, S.H., Kang, H.K., Sohn, J.W., Shin, D.W. and Lee, H., 2023. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clinical Infectious Diseases, 76(3), pp.e973-e981.
31. Chu, A.L., Lecca, L.W., Calderón, R.I., Contreras, C.C., Yataco, R.M., Zhang, Z., Becerra, M.C., Murray, M.B. and Huang, C.C., 2021. Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts. Clinical Infectious Diseases, 73(8), pp.1500-1506.
32. Chung, C., Lee, K.N., Han, K., Park, J., Shin, D.W. and Lee, S.W., 2024. Association between alcohol consumption and risk of developing tuberculosis in patients with diabetes: a nationwide retrospective cohort study. Respiratory Research, 25(1), p.420.
33. Chung, E., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H., Kim, H., Choi, H. and Kang, Y.A., 2024. Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study. The Korean Journal of Internal Medicine, 39(2), p.306.
34. Chung, C., Lee, S.W., Jeong, D., Choi, H., Sohn, H., Jeon, D. and Kang, Y.A., 2025. Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020. Journal of Infection and Public Health, 18(5), p.102723.
35. Clark, R.A., Mukandavire, C., Portnoy, A., Weerasuriya, C.K., Deol, A., Scarponi, D., Iskauskas, A., Bakker, R., Quaife, M., Malhotra, S. and Gebreselassie, N., 2023. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. The Lancet Global Health, 11(4), pp.e546-e555.
36. Clearesta, K.E., Mayangsari, A.S.M., Wati, D.K., Purniti, N.P.S., Suwarba, I.G.N.M. and Artana, I.W.D., 2024. Occurence and risk factors of tuberculosis infection in orphanage children in Bali. Paediatrica Indonesiana, 64(2), pp.152-9.
37. Cox SR, Moe AH, Gupte AN, Kadam A, Valawalkar S, Gupte N, Lele G, Kendall EA, Baillie C, Barthwal MS, Kakrani A. A point-of-care prediction tool for recurrent tuberculosis. Clinical Infectious Diseases. 2025 Dec 15;81(6):e612-22.
38. Critchley JA, Limb ES, Khakharia A, Carey IM, Auld SC, De Wilde S, Harris T, Phillips LS, Cook DG, Rhee MK, Chaudhry UA. Tuberculosis and increased incidence of cardiovascular disease: cohort study using United States and United Kingdom health records. Clinical Infectious Diseases. 2025 Feb 15;80(2):271-9.